New biopsy technique may improve sarcoidosis diagnosis
NCT ID NCT07246876
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This study will compare two ways to diagnose sarcoidosis, a disease that causes inflammation and lumps (granulomas) in the lungs. About 469 people with suspected stage I or II sarcoidosis will be randomly assigned to receive either a newer method called EBUS-guided cryobiopsy or the standard combination of biopsies. The goal is to see which approach finds granulomas more often and has fewer complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If this trial succeeds, it could show that a newer biopsy method (cryobiopsy) is better at diagnosing sarcoidosis than the current standard approach.
- What could go wrong
- This is a diagnostic study, not a treatment trial. Even if one method is more accurate, it may not change patient outcomes. The trial has not yet started recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOIDOSIS, PULMONARY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
China-Japan Friendship Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a monthly shot beat daily pills for lung sarcoidosis?
- Weight loss drug ozempic tested in lung disease patients
- Could antibiotics tame sarcoidosis? new study investigates
- New study aims to predict lung outcomes in sarcoidosis patients
- Can a malaria drug help sarcoidosis patients ditch steroids?
- New drug namilumab tested for lung sarcoidosis – but trial halted early